Advertisement

Topics

Alnylam Pharmaceuticals, Inc. (ALNY) PT Raised to $130.00

20:32 EST 9 Nov 2017 | Topix

The firm presently has an "equal weight" rating on the biopharmaceutical company's stock. Morgan Stanley's price target would indicate a potential downside of 4.25% from the company's previous close.

Original Article: Alnylam Pharmaceuticals, Inc. (ALNY) PT Raised to $130.00

NEXT ARTICLE

More From BioPortfolio on "Alnylam Pharmaceuticals, Inc. (ALNY) PT Raised to $130.00"

Advertisement
Quick Search
Advertisement
Advertisement